Business Context and Reporting Period
This Form 8-K Current Report was filed by Bioflamex Corporation (noted as Cann American Corp. in metadata) on October 15, 2012. The registrant is incorporated in Nevada with principal executive offices in Charlottenlund, Denmark. The report addresses corporate governance changes effective October 15, 2012.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance metrics.
Material Changes
- Resignation: Kenneth Bland resigned from all positions as an officer and member of the board of directors. The filing states this resignation was effective October 15, 2010, though reported in this 2012 filing. There was no known disagreement regarding operations or policies.
- Appointments: On October 15, 2012, Kristian Schiorring was appointed President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, and Director.
- Appointments: On October 15, 2012, Henrik Dahlerup was appointed Chief Operating Officer and Director.
Management Commentary and Background
Kristian Schiorring: Described as an experienced entrepreneur with a background in food, entertainment, and office/mobile supplies industries in Northern Europe. His strengths include partnerships, product development, logistics, and back-office management.
Henrik Dahlerup: Possesses 16 years of management experience in strategic marketing and consulting with major international communications corporations (Young & Rubicam, McCann, Rapp Collins, DDB). He holds a bachelor's degree in marketing from Copenhagen Business School.
The filing confirms no family relationships between the new officers and existing directors, and no material direct or indirect interests in company transactions over the last two years.
Key Facts for Investor Verification
- Verify the discrepancy regarding Kenneth Bland's resignation date (stated as effective October 15, 2010, in a report dated October 15, 2012).
- Confirm the operational status and financial health of the company, as this filing contains no financial data.
- Review the specific roles and responsibilities of the newly appointed CEO/CFO (Schiorring) and COO (Dahlerup) to assess management continuity.
- Check for any subsequent filings regarding the company's pending IRS Employer Identification Number and Commission File Number status.